Skip to main content

Table 2 Effect of CoQ10 intervention on adipokinesa

From: Coenzyme Q10 supplementation improves adipokine profile in dyslipidemic individuals: a randomized controlled trial

Adipokines Placebo group
(n = 50)
CoQ10 group
(n = 51)
pb
Adiponectin, ng/mL
 Baseline 5578 (4471, 6939) 5503 (4415, 7561) 0.897
 12 week 5648 (4210, 6847) 5668 (4626, 7740) 0.237
 24 week 5899 (4308, 6842) 5890 (4848, 8224) 0.154
 12-week changec − 78 (− 308, 65) 165 (0, 362)  < 0.001
 24-week changed 0.00 (− 288, 145) 523 (0, 1056)  < 0.001
Leptin, ng/mL
 Baseline 10.35 (5.98, 16.82) 13.43 (6.09, 20.35) 0.446
 12 week 8.37 (6.11, 14.71) 13.98 (6.16, 18.29) 0.156
 24 week 8.28 (6.11, 15.21) 12.34 (5.75, 20.19) 0.153
 12-week change 0.00 (− 1.79, 0.84) 0.00 (− 0.80, 0.86) 0.728
 24-week change 0.00 (− 3.16, 1.77) 0.30 (− 0.10, 3.39) 0.177
Resistin, ng/mL
 Baseline 8.78 (3.79, 14.62) 11.40 (5.67, 14.45) 0.448
 12 week 10.55 (4.48, 15.22) 12.14 (6.26, 14.60) 0.526
 24 week 10.90 (4.56, 16.31) 6.20 (3.15, 13.15) 0.057
 12-week change 0.12 (− 0.45, 1.76) 0.09 (− 0.13, 0.50) 0.868
 24-week change 0.36 (− 0.37, 1.64) − 1.19 (− 4.35, 0.00)  < 0.001
  1. avariables are presented as median (with upper and lower quartiles)
  2. bp value from comparison between two groups using Mann–Whitney U test at baseline, week 12, week 24, 12-week change and 24-week change, respectively
  3. c12-week change = adipokine value at week 12—adipokine value at baseline
  4. d24-week change = adipokine value at week 24—adipokine value at baseline